AD
Ashi Dayal
About Ashi Dayal
Data last updated:
Ashi Dayal is a Director at Uas Pharmaceuticals (India) Private Limited (since 2015). The company operates in Consumer Goods. Uas Pharmaceuticals (India) Private Limited reported revenue of ₹1.86 Cr (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 31 Mar 2015 | 2007 | ₹1.86 Cr (FY 2019) | Active |
Board colleagues of Ashi Dayal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajit Kumar Seth | 02158657 | Uas Pharmaceuticals (India) Private Limited | Director |
| Anuj Seth | 02668005 | Uas Pharmaceuticals (India) Private Limited | Director |
| Urvashi Seth | 02158660 | Uas Pharmaceuticals (India) Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ashi Dayal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ashi Dayal
Ashi Dayal currently holds 1 directorship: Uas Pharmaceuticals (India) Private Limited (Director, since 31 Mar 2015, revenue ₹1.86 Cr (FY 2019)).
Ashi Dayal was first appointed on 31 Mar 2015 as Director at Uas Pharmaceuticals (India) Private Limited.
The current boards of Ashi Dayal's companies include Ajit Kumar Seth (Uas Pharmaceuticals (India) Private Limited), Anuj Seth (Uas Pharmaceuticals (India) Private Limited), Urvashi Seth (Uas Pharmaceuticals (India) Private Limited).